Clinical analysis of drug treatment trends for coronary heart disease in China - Top-Institutions - MDSpire

Clinical analysis of drug treatment trends for coronary heart disease in China

  • By

  • Xu Li

  • Junyi Lou

  • Xiaoyu Li

  • Shuang Li

  • Junxian Gu

  • Die Zhang

  • Zining Luo

  • Junjie Cao

  • Jiebin Xie

  • June 9, 2026

  • 0 min

Share

Top Institutions in Cardiology

Brief introduction explaining scope and methodology.

  • #1

    National Center for Cardiovascular Diseases (NCCD) of China / Fuwai Hospital, Chinese Academy of Medical Sciences
    National Center for Cardiovascular Diseases (NCCD) of China / Fuwai Hospital, Chinese Academy of Medical Sciences

    Beijing, China

    Key Differentiators

    • Cardiology

  • #2

    Yale University – Center for Outcomes Research & Evaluation (CORE) / Yale New Haven Hospital
    Yale University – Center for Outcomes Research & Evaluation (CORE) / Yale New Haven Hospital

    New Haven, Connecticut

    Key Differentiators

    • Cardiology

Original Source(s)

Clinical analysis of drug treatment trends for coronary heart disease in China

  • by Xu Li, Junyi Lou, Xiaoyu Li, Shuang Li, Junxian Gu, Die Zhang, Zining Luo, Junjie Cao, Jiebin Xie

  • June 9, 2026

Related Content

Baseline vs. on-treatment heart failure with preserved ejection fraction (HFpEF) in a real world cardio-oncology clinic: observational analysis of cancer therapy-related cardiovascular toxicity incidence and cancer treatment implications

Single-cell transcriptomic insights into the immune heterogeneity of immune checkpoint inhibitors related organ toxicities

Association of estimated glomerular filtration rate and in-hospital mortality in patients hospitalized for heart failure: a retrospective cohort study